Fosco Bernasconi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fosco Bernasconi has a total of 147 co-authors. Here are the top co-authors by number of shared publications:
- Olaf Blanke
Laboratory of Cognitive Neuroscience, Neuro-X Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, EPFL, Geneva, Switzerland
26 shared publications - Jevita Potheegadoo
Laboratory of Cognitive Neuroscience, Neuro-X Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne, EPFL, Geneva, Switzerland
13 shared publications - Lucas Spierer
Laboratory for Neurorehabilitation Science, Medicine Section, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
11 shared publications - Nathan Faivre
Université Grenoble Alpes
11 shared publications Olaf Blanke
Laboratory of Cognitive Neuroscience, Neuro-X Institute & Brain Mind Institute, Faculty of Life Sciences, Swiss Federal Institute of Technology (EPFL)
10 shared publications- Micah M. Murray
Department of Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
9 shared publications
Latest Publications
- 11 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (875)
Sleep-like slow waves during wakefulness are associated with hallucinations and poorer cognition in Parkinson’s disease
Slow waves during sleep are fundamental for neural homeostasis, metabolic regulation, and waste clearance and are known to be altered in neurodegenerative diseases. Sleep-like slow waves (SLSWs) have been observed in awake, healthy individuals, where they are linked to fluctuations in vigilance and mind-wandering. Whether SLSWs are altered in Parkinson’s disease (PD), and whether such alterations contribute to psychiatric or cognitive complications, remains unknown. In a cohort of 84 nondemented patients with PD and 30 healthy older adults, we found that SLSWs occurred more frequently in patients with PD. Hallucinatory traits in patients with PD were associated with higher SLSW amplitude, especially over frontocentral regions. Moreover, more prominent SLSWs were associated with poorer cognitive functions. We conclude that, whereas slow waves during sleep have positive physiological functions, exacerbated diurnal SLSWs may reflect responses related to PD neuropathology, at the cost of hallucinations and reduced cognitive function.
- 11 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (875)
Sleep-like slow waves during wakefulness are associated with hallucinations and poorer cognition in Parkinson’s disease
Slow waves during sleep are fundamental for neural homeostasis, metabolic regulation, and waste clearance and are known to be altered in neurodegenerative diseases. Sleep-like slow waves (SLSWs) have been observed in awake, healthy individuals, where they are linked to fluctuations in vigilance and mind-wandering. Whether SLSWs are altered in Parkinson’s disease (PD), and whether such alterations contribute to psychiatric or cognitive complications, remains unknown. In a cohort of 84 nondemented patients with PD and 30 healthy older adults, we found that SLSWs occurred more frequently in patients with PD. Hallucinatory traits in patients with PD were associated with higher SLSW amplitude, especially over frontocentral regions. Moreover, more prominent SLSWs were associated with poorer cognitive functions. We conclude that, whereas slow waves during sleep have positive physiological functions, exacerbated diurnal SLSWs may reflect responses related to PD neuropathology, at the cost of hallucinations and reduced cognitive function.
- Open Access
- 30 October 2026
- Published by Springer Nature in npj Parkinson's Disease
Parkinson’s disease progression and fronto-temporal disconnection relate to identity of minor hallucinations
Presence hallucinations (PH), a non-veridical perceptions of someone appearing around you, are frequent symptoms in Parkinson’s disease (PD). They belong to the group of minor hallucinations, predicting later appearance of structured visual hallucinations and PD psychosis. Despite their elevated frequency and negative clinical outcomes, differences in PH subtypes have not been examined. Investigating PD patients with identified versus unidentified PH, this study aims to determine differences in disease progression, motor and cognitive performance, and brain mechanisms. From 77 PD patients, 27 reporting PH were grouped into those with identified PH versus unidentified PH (iPH-PD, n = 12; uPH-PD, n = 15). Disease progression (UPDRS, Hoehn Yahr), cognitive functions (PD-CRS) (with exploratory analysis of all clinical variables, uncorrected for multiple comparisons), sensitivity to robot-induced PH and resting-state functional connectivity were analysed. iPH reports mostly consisted of first-degree close others (e.g., partner). iPH-PD patients had a more advanced PD stage, reported more daily-life motor impairments and simple visual illusions than uPH-PD patients. Both groups showed similar sensitivity to robot-induced PH. Resting-state functional connectivity showed that iPH-PD vs. uPH-PD patients had right IFG-pMTG functional disconnection within a previously defined PH network and the degree of this disconnection correlated with posterior cognitive impairment. Distinguishing iPH-PD from uPH-PD patients, we show that the former display worse daily motor functioning, more frequent visual illusions and stronger fronto-temporal disconnection, related to cognitive dysfunction. Although the present findings need to be confirmed in larger samples, they suggest that iPH-PD have a more advanced form of PD, possibly representing an intermediate disease stage, between uPH-PD and PD patients with structured visual hallucinations.
- 30 October 2026
- Published by Springer Nature in npj Parkinson's Disease
Open AccessParkinson’s disease progression and fronto-temporal disconnection relate to identity of minor hallucinations
Presence hallucinations (PH), a non-veridical perceptions of someone appearing around you, are frequent symptoms in Parkinson’s disease (PD). They belong to the group of minor hallucinations, predicting later appearance of structured visual hallucinations and PD psychosis. Despite their elevated frequency and negative clinical outcomes, differences in PH subtypes have not been examined. Investigating PD patients with identified versus unidentified PH, this study aims to determine differences in disease progression, motor and cognitive performance, and brain mechanisms. From 77 PD patients, 27 reporting PH were grouped into those with identified PH versus unidentified PH (iPH-PD, n = 12; uPH-PD, n = 15). Disease progression (UPDRS, Hoehn Yahr), cognitive functions (PD-CRS) (with exploratory analysis of all clinical variables, uncorrected for multiple comparisons), sensitivity to robot-induced PH and resting-state functional connectivity were analysed. iPH reports mostly consisted of first-degree close others (e.g., partner). iPH-PD patients had a more advanced PD stage, reported more daily-life motor impairments and simple visual illusions than uPH-PD patients. Both groups showed similar sensitivity to robot-induced PH. Resting-state functional connectivity showed that iPH-PD vs. uPH-PD patients had right IFG-pMTG functional disconnection within a previously defined PH network and the degree of this disconnection correlated with posterior cognitive impairment. Distinguishing iPH-PD from uPH-PD patients, we show that the former display worse daily motor functioning, more frequent visual illusions and stronger fronto-temporal disconnection, related to cognitive dysfunction. Although the present findings need to be confirmed in larger samples, they suggest that iPH-PD have a more advanced form of PD, possibly representing an intermediate disease stage, between uPH-PD and PD patients with structured visual hallucinations.
- Open Access
- 9 October 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
Dopaminergic state modulates shame and contextual emotional responses in Parkinson's disease
Background: Shame is frequent in Parkinson's disease (PD) and negatively affects quality of life, yet its dopaminergic modulation remains unclear. Methods: We investigated the effect of dopaminergic replacement therapy (DRT) on shame in 41 fluctuating PD patients using an experimental tailored shame induction task. At visit 1, participants were presented with 60 short written scenarios (neutral, non-PD-related shame, PD-related shame). A tailored selection of 12 scenarios (4 per category) was generated in three steps: (1) initial rating of all 60 scenarios on a shame/embarrassment visual analogue scale (VAS); (2) selection of the highest-rated scenarios for shame conditions and lowest-rated scenarios for neutral condition to account for individual emotional relevance; and (3) emotional rating of these scenarios on 10 VAS (fear, sadness, disgust, joy, self- and other-directed anger, shame, embarrassment, guilt, stress) to ensure specificity of shame/embarrassment responses. At visits 2 and 3, patients rated the 12 scenarios once ON- and once OFF-DRT (randomized crossover design) using the same 10 VAS. Results: In OFF-DRT state, shame ratings were lower than in ON-DRT for non-PD-related shame scenarios (Zratio = −2.53, p = 0.02), with a similar trend for PD-related shame scenarios (Zratio = −2.02, p = 0.06). Conversely, patients reported higher embarrassment (Zratio = 4.53, p < 0.001), stress (Zratio = 3.49, p < 0.001), and self-directed anger (Zratio = 3.99, p < 0.001) when evaluating scenarios rated as neutral in the ON-DRT state. Conclusions: In OFF-DRT state, emotional responses showed altered contextual calibration, with reduced shame in shame-eliciting contexts and increased negative emotions in neutral situations. These findings suggest that dopaminergic state may modulate intensity and appraisal processes of emotions.
- 9 October 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
Open AccessDopaminergic state modulates shame and contextual emotional responses in Parkinson's disease
Background: Shame is frequent in Parkinson's disease (PD) and negatively affects quality of life, yet its dopaminergic modulation remains unclear. Methods: We investigated the effect of dopaminergic replacement therapy (DRT) on shame in 41 fluctuating PD patients using an experimental tailored shame induction task. At visit 1, participants were presented with 60 short written scenarios (neutral, non-PD-related shame, PD-related shame). A tailored selection of 12 scenarios (4 per category) was generated in three steps: (1) initial rating of all 60 scenarios on a shame/embarrassment visual analogue scale (VAS); (2) selection of the highest-rated scenarios for shame conditions and lowest-rated scenarios for neutral condition to account for individual emotional relevance; and (3) emotional rating of these scenarios on 10 VAS (fear, sadness, disgust, joy, self- and other-directed anger, shame, embarrassment, guilt, stress) to ensure specificity of shame/embarrassment responses. At visits 2 and 3, patients rated the 12 scenarios once ON- and once OFF-DRT (randomized crossover design) using the same 10 VAS. Results: In OFF-DRT state, shame ratings were lower than in ON-DRT for non-PD-related shame scenarios (Zratio = −2.53, p = 0.02), with a similar trend for PD-related shame scenarios (Zratio = −2.02, p = 0.06). Conversely, patients reported higher embarrassment (Zratio = 4.53, p < 0.001), stress (Zratio = 3.49, p < 0.001), and self-directed anger (Zratio = 3.99, p < 0.001) when evaluating scenarios rated as neutral in the ON-DRT state. Conclusions: In OFF-DRT state, emotional responses showed altered contextual calibration, with reduced shame in shame-eliciting contexts and increased negative emotions in neutral situations. These findings suggest that dopaminergic state may modulate intensity and appraisal processes of emotions.
- Open Access
Dopaminergic therapy selectively amplifies hallucination susceptibility in patients with Parkinson’s disease with cortico-striatal hyperconnectivity
Dopamine replacement therapy (DRT) alleviates motor symptoms in Parkinson’s disease (PD) but can trigger hallucinations in a subset of patients, yet the neural basis of this selective vulnerability is unknown. Hallucinations are among the most disabling non-motor symptoms of PD, linked to social isolation, dementia and institutionalization. Using a validated robotic paradigm to induce and quantify hallucinations in real-time, combined with resting-state fMRI in a crossover On/Off DRT design, we studied patients with PD with (PD-H) and without (PD-nH) hallucinations. DRT selectively amplified sensitivity to robot-induced hallucinations in patients with pre-existing hallucinatory phenotype (PD-H, but not PD-nH) and was accompanied by cortico-striatal and large-scale network hyperconnectivity. Rather than supporting a uniform hallucinogenic effect of dopamine in PD, these findings indicate that DRT interacts with an intrinsic neural vulnerability that varies in patients. Prospective studies will establish whether this pharmacological–behavioural signature identifies patients at risk before clinical hallucinations emerge.
Open AccessDopaminergic therapy selectively amplifies hallucination susceptibility in patients with Parkinson’s disease with cortico-striatal hyperconnectivity
Dopamine replacement therapy (DRT) alleviates motor symptoms in Parkinson’s disease (PD) but can trigger hallucinations in a subset of patients, yet the neural basis of this selective vulnerability is unknown. Hallucinations are among the most disabling non-motor symptoms of PD, linked to social isolation, dementia and institutionalization. Using a validated robotic paradigm to induce and quantify hallucinations in real-time, combined with resting-state fMRI in a crossover On/Off DRT design, we studied patients with PD with (PD-H) and without (PD-nH) hallucinations. DRT selectively amplified sensitivity to robot-induced hallucinations in patients with pre-existing hallucinatory phenotype (PD-H, but not PD-nH) and was accompanied by cortico-striatal and large-scale network hyperconnectivity. Rather than supporting a uniform hallucinogenic effect of dopamine in PD, these findings indicate that DRT interacts with an intrinsic neural vulnerability that varies in patients. Prospective studies will establish whether this pharmacological–behavioural signature identifies patients at risk before clinical hallucinations emerge.
- Open Access
- 23 July 2026
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Altered heart-brain coupling in awake patients with isolated REM sleep behaviour disorder
Isolated REM sleep behaviour disorder (iRBD) represents a prodromal stage of alpha-synucleinopathies, frequently preceding Parkinson’s disease and dementia with Lewy bodies. Beyond the characteristic sleep disturbances, alterations in brain-body coupling, reflecting neural peripheral physiological interactions, have yet to be determined. Using whole-night polysomnography, we quantified brain-body coupling via heartbeat evoked potentials (HEPs) across wakefulness, NREM, and REM sleep. Individuals with iRBD ( n = 13) were compared with healthy controls ( n = 23), alongside analyses of ECG-derived features. During wakefulness, iRBD patients showed altered HEPs over frontal regions between 305 and 445 ms after the R-peak. No significant group differences were observed during NREM or REM sleep, and HEP amplitude alterations were not explained by ECG differences. These diurnal HEP changes may represent a novel quantitative biomarker for iRBD during wakefulness and, in the future, could serve as a marker for phenoconversion to alpha-synucleinopathy.
- 23 July 2026
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 12 (1)
Open AccessAltered heart-brain coupling in awake patients with isolated REM sleep behaviour disorder
Isolated REM sleep behaviour disorder (iRBD) represents a prodromal stage of alpha-synucleinopathies, frequently preceding Parkinson’s disease and dementia with Lewy bodies. Beyond the characteristic sleep disturbances, alterations in brain-body coupling, reflecting neural peripheral physiological interactions, have yet to be determined. Using whole-night polysomnography, we quantified brain-body coupling via heartbeat evoked potentials (HEPs) across wakefulness, NREM, and REM sleep. Individuals with iRBD ( n = 13) were compared with healthy controls ( n = 23), alongside analyses of ECG-derived features. During wakefulness, iRBD patients showed altered HEPs over frontal regions between 305 and 445 ms after the R-peak. No significant group differences were observed during NREM or REM sleep, and HEP amplitude alterations were not explained by ECG differences. These diurnal HEP changes may represent a novel quantitative biomarker for iRBD during wakefulness and, in the future, could serve as a marker for phenoconversion to alpha-synucleinopathy.
- Open Access
- 6 May 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 16 (6) , 1150-1163
Frontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts
Background: Minor hallucinations (MH) affect 30–60% of patients with Parkinson's disease (PD), and are considered precursors to structured visual hallucinations and cognitive decline. While the link between structured visual hallucinations and dementia is well established, the neuropsychological correlates of MH in PD remain unclear; most studies finding no significant cognitive differences between patients with MH and those without any hallucinations. Objectives: Presence hallucinations (PH) being among the most prevalent MH in PD, we used a robotic procedure delivering somatomotor conflicts inducing PH experimentally to investigate whether sensitivity to such robot-induced PH aids in detecting cognitive differences between patients with MH and without hallucinations. Methods: 31 PD patients with MH (PD-MH) and 37 without hallucinations (PD-nH) underwent neuropsychological assessment and the robotic procedure inducing PH. The sensitivity to report robot-induced PH was analyzed in relation to cognitive performance in neuropsychological tests. Results: PD-MH patients reported more robot-induced PH than PD-nH patients, supporting previous findings. While both groups showed comparable performance in neuropsychological testing, we found a significant association between increased sensitivity to the PH-induction and poorer performance in frontal subcortical cognitive functions, in PD-MH patients, but not in PD-nH patients. Conclusions: These findings demonstrate that sensitivity to robot-induced PH reveals a previously undetected link between MH and frontal subcortical cognitive deficits in PD, pointing to shared underlying mechanisms between executive dysfunction and somatomotor processes involved in MH. This approach offers a novel and clinically valuable means of identifying early cognitive vulnerability that assessments relying only on standard testing may overlook.
- 6 May 2026
- Published by SAGE Publications in Journal of Parkinson’s Disease
- Vol. 16 (6) , 1150-1163
Open AccessFrontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts
Background: Minor hallucinations (MH) affect 30–60% of patients with Parkinson's disease (PD), and are considered precursors to structured visual hallucinations and cognitive decline. While the link between structured visual hallucinations and dementia is well established, the neuropsychological correlates of MH in PD remain unclear; most studies finding no significant cognitive differences between patients with MH and those without any hallucinations. Objectives: Presence hallucinations (PH) being among the most prevalent MH in PD, we used a robotic procedure delivering somatomotor conflicts inducing PH experimentally to investigate whether sensitivity to such robot-induced PH aids in detecting cognitive differences between patients with MH and without hallucinations. Methods: 31 PD patients with MH (PD-MH) and 37 without hallucinations (PD-nH) underwent neuropsychological assessment and the robotic procedure inducing PH. The sensitivity to report robot-induced PH was analyzed in relation to cognitive performance in neuropsychological tests. Results: PD-MH patients reported more robot-induced PH than PD-nH patients, supporting previous findings. While both groups showed comparable performance in neuropsychological testing, we found a significant association between increased sensitivity to the PH-induction and poorer performance in frontal subcortical cognitive functions, in PD-MH patients, but not in PD-nH patients. Conclusions: These findings demonstrate that sensitivity to robot-induced PH reveals a previously undetected link between MH and frontal subcortical cognitive deficits in PD, pointing to shared underlying mechanisms between executive dysfunction and somatomotor processes involved in MH. This approach offers a novel and clinically valuable means of identifying early cognitive vulnerability that assessments relying only on standard testing may overlook.
- Open Access
Altered heart-brain coupling in awake patients with isolated REM sleep behaviour disorder
Isolated REM Sleep Behaviour Disorder (iRBD) represents an early stage of α-synucleinopathy, often preceding Parkinson’s disease, dementia with Lewy bodies or Multiple System Atrophy. Growing evidence shows that iRBD patients are not only characterized by sleep disturbances but also dysautonomia. However, whether the brain–body coupling reflecting the interaction between neural and peripheral physiological activity is altered in iRBD remains unknown. Leveraging whole-night polysomnography data from thirty-six participants, we quantified heart–brain coupling via heartbeat evoked potentials (HEPs) across wakefulness, NREM, and REM sleep. HEPs were compared between individuals with isolated REM sleep behavior disorder (iRBD; n = 13) and healthy controls (HC; n = 23). In addition, heart rate variability (HRV) and other ECG-derived features were analyzed. During wakefulness, iRBD patients showed altered HEP compared to HC, between 230 and 445 ms after the R-peak. over frontal regions. The duration of RBD symptoms was positively associated with the magnitude of these HEP alterations. HEP alterations were specific to wakefulness, as no differences were observed during NREM or REM sleep. Additional analyses showed that HEP alterations in iRBD during wakefulness were not driven by ECG differences. We corroborate previous findings of altered heart rate variability (HRV) in iRBD patients during REM sleep. We demonstrate that brain-body coupling, as indexed by HEP, is altered during wakefulness in iRBD patients. These diurnal HEP may represent a novel quantitative biomarker of iRBD, and could, in the future, serve as a marker for the phenoconversion to α-synucleinopathy.
Open AccessAltered heart-brain coupling in awake patients with isolated REM sleep behaviour disorder
Isolated REM Sleep Behaviour Disorder (iRBD) represents an early stage of α-synucleinopathy, often preceding Parkinson’s disease, dementia with Lewy bodies or Multiple System Atrophy. Growing evidence shows that iRBD patients are not only characterized by sleep disturbances but also dysautonomia. However, whether the brain–body coupling reflecting the interaction between neural and peripheral physiological activity is altered in iRBD remains unknown. Leveraging whole-night polysomnography data from thirty-six participants, we quantified heart–brain coupling via heartbeat evoked potentials (HEPs) across wakefulness, NREM, and REM sleep. HEPs were compared between individuals with isolated REM sleep behavior disorder (iRBD; n = 13) and healthy controls (HC; n = 23). In addition, heart rate variability (HRV) and other ECG-derived features were analyzed. During wakefulness, iRBD patients showed altered HEP compared to HC, between 230 and 445 ms after the R-peak. over frontal regions. The duration of RBD symptoms was positively associated with the magnitude of these HEP alterations. HEP alterations were specific to wakefulness, as no differences were observed during NREM or REM sleep. Additional analyses showed that HEP alterations in iRBD during wakefulness were not driven by ECG differences. We corroborate previous findings of altered heart rate variability (HRV) in iRBD patients during REM sleep. We demonstrate that brain-body coupling, as indexed by HEP, is altered during wakefulness in iRBD patients. These diurnal HEP may represent a novel quantitative biomarker of iRBD, and could, in the future, serve as a marker for the phenoconversion to α-synucleinopathy.
- Open Access
- 15 September 2025
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 35 (9)
Extrastriate activity reflects sensorimotor-induced bias in estimating number of visual humans
Humans and animals are able to rapidly, and with reasonable accuracy, estimate the number of objects in a visual scene. Visual-evoked potential studies have described a sequence of functionally distinct stages associated with numerosity perception. Recently, a specialized cognitive-perceptual system for the numerosity estimation for human stimuli (NEH), distinct from that for non-social stimuli, was revealed using virtual reality, revealing a stable NEH overestimation bias (ie perceiving more people than were shown). This bias was further increased when a social hallucination characterized by the false perception of another invisible person (presence hallucination) was induced robotically and repeatedly prior to NEH trials. However, little is known about the brain mechanisms of NEH and robot-induced presence hallucination. Here we combined virtual reality and robotically-induced presence hallucination with visual-evoked potentials to investigate the neural mechanisms and processing steps of NEH. We report that NEH induces numerosity-related components as observed for non-human numerosity stimuli and, critically that experimentally-induced presence hallucination selectively modulated the P2p component, whose amplitude correlated with NEH overestimation magnitude. This effect was localized in left extrastriate cortex, showing that robot-induced presence hallucination are integrated with NEH processing during the P2p time period and relying on social numerosity mechanisms in extrastriate cortex.
- 15 September 2025
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 35 (9)
Open AccessExtrastriate activity reflects sensorimotor-induced bias in estimating number of visual humans
Humans and animals are able to rapidly, and with reasonable accuracy, estimate the number of objects in a visual scene. Visual-evoked potential studies have described a sequence of functionally distinct stages associated with numerosity perception. Recently, a specialized cognitive-perceptual system for the numerosity estimation for human stimuli (NEH), distinct from that for non-social stimuli, was revealed using virtual reality, revealing a stable NEH overestimation bias (ie perceiving more people than were shown). This bias was further increased when a social hallucination characterized by the false perception of another invisible person (presence hallucination) was induced robotically and repeatedly prior to NEH trials. However, little is known about the brain mechanisms of NEH and robot-induced presence hallucination. Here we combined virtual reality and robotically-induced presence hallucination with visual-evoked potentials to investigate the neural mechanisms and processing steps of NEH. We report that NEH induces numerosity-related components as observed for non-human numerosity stimuli and, critically that experimentally-induced presence hallucination selectively modulated the P2p component, whose amplitude correlated with NEH overestimation magnitude. This effect was localized in left extrastriate cortex, showing that robot-induced presence hallucination are integrated with NEH processing during the P2p time period and relying on social numerosity mechanisms in extrastriate cortex.
- Open Access
Sleep-like slow waves during wakefulness uncover a malignant form of Parkinson’s disease
Slow waves during sleep are fundamental for neural homeostasis, metabolic regulation, and waste clearance, and are known to be altered in neurodegenerative diseases. Sleep-like slow waves (SLSW) have been observed in awake healthy individuals, where they are linked to fluctuating vigilance and mind-wandering. Whether SLSW are altered in Parkinson’s disease (PD), and whether such alterations contribute to psychiatric or cognitive complications, remains unknown. In a cohort of 84 non-demented PD patients and 30 healthy older adults, we found that SLSW occurred more frequently in PD. Hallucinatory traits in PD were associated with higher SLSW amplitude, especially over fronto-central regions, and the extent of SLSW alterations was associated with the severity of hallucinatory burden. Moreover, more prominent SLSW predicted greater cognitive impairment. We conclude that, while slow waves during sleep have positive physiological functions, exacerbated diurnal SLSW may represent reactions related to the PD neuropathology, at the cost of hallucinations and cognitive impairment.
Open AccessSleep-like slow waves during wakefulness uncover a malignant form of Parkinson’s disease
Slow waves during sleep are fundamental for neural homeostasis, metabolic regulation, and waste clearance, and are known to be altered in neurodegenerative diseases. Sleep-like slow waves (SLSW) have been observed in awake healthy individuals, where they are linked to fluctuating vigilance and mind-wandering. Whether SLSW are altered in Parkinson’s disease (PD), and whether such alterations contribute to psychiatric or cognitive complications, remains unknown. In a cohort of 84 non-demented PD patients and 30 healthy older adults, we found that SLSW occurred more frequently in PD. Hallucinatory traits in PD were associated with higher SLSW amplitude, especially over fronto-central regions, and the extent of SLSW alterations was associated with the severity of hallucinatory burden. Moreover, more prominent SLSW predicted greater cognitive impairment. We conclude that, while slow waves during sleep have positive physiological functions, exacerbated diurnal SLSW may represent reactions related to the PD neuropathology, at the cost of hallucinations and cognitive impairment.
- Open Access
Frontal subcortical executive dysfunction and minor hallucinations in Parkinson’s disease are linked to sensitivity to somatomotor conflicts
Background: Minor hallucinations (MH) affect 30-60% of patients with Parkinson’s disease (PD), and are considered precursors to structured visual hallucinations and cognitive decline. While the link between structured visual hallucinations and dementia is well established, the neuropsychological correlates of MH in PD remain unclear; most studies finding no significant cognitive differences between patients with MH and those without any hallucinations. Objectives: Presence hallucinations (PH) being among the most prevalent MH in PD, we used a robotic procedure delivering somatomotor conflicts inducing PH experimentally to investigate whether sensitivity to such robot-induced PH aids in detecting cognitive differences between patients with MH and without hallucinations. Methods: 31 PD patients with MH (PD-MH) and 37 without hallucinations (PD-nH) underwent neuropsychological assessment and the robotic procedure inducing PH. The sensitivity to report robot-induced PH was analyzed in relation to cognitive performance in neuropsychological tests. Results: PD-MH patients reported more robot-induced PH than PD-nH patients, supporting previous findings. While both groups showed comparable performance in neuropsychological testing, we found a significant association between increased sensitivity to the PH-induction and poorer performance in frontal subcortical functions (executive functions), in PD-MH patients, but not in PD-nH patients. Conclusions: These findings demonstrate that sensitivity to robot-induced PH reveals a previously undetected link between MH and frontal subcortical cognitive deficits in PD, pointing to shared underlying mechanisms between executive dysfunction and somatomotor processes involved in MH. This approach offers a novel and clinically valuable means of identifying early cognitive vulnerability that assessments relying only on standard testing may overlook. Plain language summary: Induced minor hallucinations are linked to executive function alteration in Parkinson’s disease: This study investigated two groups of Parkinson’s disease (PD) patients: one group with minor hallucinations (MH) and another without any hallucinations. Using cognitive tests and a robotic task designed to temporarily induce a presence hallucination (hallucination of someone being there when no one is actually present), the study examined the relationship between cognitive impairment and sensitivity to robot-induced presence hallucinations (riPH). While both groups performed similarly on traditional cognitive tests, patients with MH were more sensitive to the riPH procedure. This increased riPH sensitivity was linked to difficulties with cognitive functions, especially executive functions, which are generally supported by the brain’s frontal and deeper regions (frontal subcortical network). These results from both tests (riPH, neuropsychology) suggest that elevated sensitivity to riPH is associated with mild signs of cognitive decline in PD patients that traditional tests might not detect. The use of the robotic induction of hallucinations as a tool for assessing cognitive deficits could offer a more sensitive method for identifying cognitive issues earlier in PD, potentially enabling earlier interventions.
Open AccessFrontal subcortical executive dysfunction and minor hallucinations in Parkinson’s disease are linked to sensitivity to somatomotor conflicts
Background: Minor hallucinations (MH) affect 30-60% of patients with Parkinson’s disease (PD), and are considered precursors to structured visual hallucinations and cognitive decline. While the link between structured visual hallucinations and dementia is well established, the neuropsychological correlates of MH in PD remain unclear; most studies finding no significant cognitive differences between patients with MH and those without any hallucinations. Objectives: Presence hallucinations (PH) being among the most prevalent MH in PD, we used a robotic procedure delivering somatomotor conflicts inducing PH experimentally to investigate whether sensitivity to such robot-induced PH aids in detecting cognitive differences between patients with MH and without hallucinations. Methods: 31 PD patients with MH (PD-MH) and 37 without hallucinations (PD-nH) underwent neuropsychological assessment and the robotic procedure inducing PH. The sensitivity to report robot-induced PH was analyzed in relation to cognitive performance in neuropsychological tests. Results: PD-MH patients reported more robot-induced PH than PD-nH patients, supporting previous findings. While both groups showed comparable performance in neuropsychological testing, we found a significant association between increased sensitivity to the PH-induction and poorer performance in frontal subcortical functions (executive functions), in PD-MH patients, but not in PD-nH patients. Conclusions: These findings demonstrate that sensitivity to robot-induced PH reveals a previously undetected link between MH and frontal subcortical cognitive deficits in PD, pointing to shared underlying mechanisms between executive dysfunction and somatomotor processes involved in MH. This approach offers a novel and clinically valuable means of identifying early cognitive vulnerability that assessments relying only on standard testing may overlook. Plain language summary: Induced minor hallucinations are linked to executive function alteration in Parkinson’s disease: This study investigated two groups of Parkinson’s disease (PD) patients: one group with minor hallucinations (MH) and another without any hallucinations. Using cognitive tests and a robotic task designed to temporarily induce a presence hallucination (hallucination of someone being there when no one is actually present), the study examined the relationship between cognitive impairment and sensitivity to robot-induced presence hallucinations (riPH). While both groups performed similarly on traditional cognitive tests, patients with MH were more sensitive to the riPH procedure. This increased riPH sensitivity was linked to difficulties with cognitive functions, especially executive functions, which are generally supported by the brain’s frontal and deeper regions (frontal subcortical network). These results from both tests (riPH, neuropsychology) suggest that elevated sensitivity to riPH is associated with mild signs of cognitive decline in PD patients that traditional tests might not detect. The use of the robotic induction of hallucinations as a tool for assessing cognitive deficits could offer a more sensitive method for identifying cognitive issues earlier in PD, potentially enabling earlier interventions.